(PharmaNewsWire.Com, July 01, 2017 ) Short bowel syndrome (SBS) is a disorder that occurs due to the malfunction of the intestine, leading to malabsorption. SBS can be a consequence of several underlying diseases or medical conditions which can cause resection of the intestine. Due to this the nutrient processing areas of the intestine are rendered dysfunction and can also lead to dangerous infectious and other metabolic disorders. A new research report with a title “Global Short Bowel Syndrome (SBS) Market” Research Report 2017 has been recently added to massive online database of Market Research Hub (MRH). This report analyzes the current as well as the future scenario of the global short bowel syndrome (SBS) market.
The disease can be congenital or a result of underlying illnesses such as intestinal failure, tumors, Crohn’s disease, injury or trauma to the small intestine. Necrotizing enterocholitis is often detected to be the cause of short bowel syndrome amongst infants and neonates. This research report projects that the postoperative complications arising out of obstructive and vascular anomalies, which need extensive resection are on the rise. These difficulties are also making a significant contribution to high prevalence SBS across the world.
In this report, the global Short Bowel Syndrome (SBS) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Short Bowel Syndrome (SBS) in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Short Bowel Syndrome (SBS) market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Emmaus Medical
Merck
Shire
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Oral Route
Parental Route
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Short Bowel Syndrome (SBS) for each application, including
Hospitals
Drugstores
Others
Table of Contents
Global Short Bowel Syndrome (SBS) Market Research Report 2017
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
